EDITAS MEDICINE, INC. Amortization of Debt Issuance Costs and Discounts
EDITAS MEDICINE, INC. (EDIT) reported Amortization of Debt Issuance Costs and Discounts of $445.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2017-03-03
- EDITAS MEDICINE, INC. amortization of debt issuance costs and discounts for the quarter ending 2015-09-30 was $17.00K.
- EDITAS MEDICINE, INC. amortization of debt issuance costs and discounts for the quarter ending 2015-06-30 was $15.00K.
- EDITAS MEDICINE, INC. amortization of debt issuance costs and discounts for the quarter ending 2015-03-31 was $13.00K.
- EDITAS MEDICINE, INC. amortization of debt issuance costs and discounts for fiscal 2016 was $445.00K.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2016-12-31 | $445.00K 10-K · filed 2017-03-03 | |||
| 2015-09-30 | $17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $32.00K derived: sum of 2 quarters · filed 2016-11-09 | $45.00K 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | $28.00K 10-Q · filed 2016-08-10 | ||
| 2015-03-31 | $13.00K 10-Q · filed 2016-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |